If it can keep up a compound annual growth rate (CAGR) of 25% during the next five years, keeping the price-to-sales ratio ...

There's record amounts of cash on the sidelines in money market funds, but putting cash to work as the market swoons can be ...

Pfizer is a solid dividend stock. Its forward yield currently tops 7%, and the company has increased its payouts by 19.5% in ...

Let's examine three of those stocks that still look dirt cheap relative to their growth potential -- Plug Power (NASDAQ: PLUG ...

An early rally faded on Friday and the Dow just missed out on closing at its first record high of the year. US stocks were ...

Investors are contemplating what seem to be contradictory trends in financial markets and wondering how long they can last. President Trump's tariffs are beginning to cause tremors in the real economy ...

The stock is quite expensive, at 150 times earnings, pricing in lofty growth expectations. With analysts projecting growth of ...

Warren Buffett’s Berkshire Hathaway (BRK.B) sold shares in Apple (AAPL) last quarter, [while adding UnitedHealth](https: ...

Socialist NYC mayoral candidate Zohran Mamdani has scored nearly $10 million in public matching funds for his campaign ...

The real assets portfolio was the primary detractor due to negative returns for energy stocks and U.S. real estate investment ...

D-Wave, IonQ and Rigetti post strong Q2 sales, incur steeper losses and have billion-dollar cash reserves to drive quantum ...

Here's why the ETF is still worth buying in August, even though it's at an all-time high. Instead of focusing solely on dividend yield, the Dividend Appreciation ETF targets companies that are growing ...